Abbott Laboratories |
Abstract
|
Heather Cartwright, Taskin Ahmed |
|
AstraZeneca |
Abstract
|
Heather Cartwright, Taskin Ahmed |
|
Bayer |
Abstract
|
Heather Cartwright, Taskin Ahmed |
|
Bristol-Myers Squibb |
Abstract
|
Heather Cartwright, Taskin Ahmed |
|
Eli Lilly |
Abstract
|
Heather Cartwright, Taskin Ahmed |
|
GlaxoSmithKline |
Abstract
|
Heather Cartwright, Taskin Ahmed |
|
Johnson & Johnson |
Abstract
|
Heather Cartwright, Taskin Ahmed |
|
Merck & Co |
Abstract
|
Heather Cartwright, Taskin Ahmed |
|
Novartis |
Abstract
|
Heather Cartwright, Taskin Ahmed |
|
Pfizer |
Abstract
|
Heather Cartwright, Taskin Ahmed |
|
Sanofi |
Abstract
|
Heather Cartwright, Taskin Ahmed |
|
Roche, GSK and Pfizer Remain the Most Prolific Big Pharma Dealmakers |
Abstract
|
Heather Cartwright, Taskin Ahmed |
|